<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="544">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05154071</url>
  </required_header>
  <id_info>
    <org_study_id>NGUYEN 2021-3</org_study_id>
    <nct_id>NCT05154071</nct_id>
  </id_info>
  <brief_title>Impact of the Implementation of a Referral Veno-venous Extracorporeal Membrane Oxygenation Centre on Mortality</brief_title>
  <acronym>ECMO UNIT</acronym>
  <official_title>Impact of the Implementation of a Referral Veno-venous Extracorporeal Membrane Oxygenation Centre on Mortality</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Current evidence suggest that regrouping patient supported by veno-venous ECMO in high-volume&#xD;
      centre could improve outcome. A dedicated ECMO unit was implemented in Dijon.&#xD;
&#xD;
      The objective of the present study was to evaluate the implementation of this unit. The&#xD;
      hypothesis was that patient taken care within this structured care system would have lower&#xD;
      mortality.&#xD;
&#xD;
      This research comprises a retrospective observational study conducted in Dijon university&#xD;
      hospital&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2021</start_date>
  <completion_date type="Actual">December 1, 2021</completion_date>
  <primary_completion_date type="Actual">November 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality rate</measure>
    <time_frame>90 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of ECMO adverse events</measure>
    <time_frame>through study completion, an average of 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>through study completion, an average of 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU length of stay</measure>
    <time_frame>through study completion, an average of 3 years</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">172</enrollment>
  <condition>Extracorporeal Membrane Oxygenation</condition>
  <arm_group>
    <arm_group_label>ECMO VV dedicated unit</arm_group_label>
    <description>Patient having benefited from an ECMO within the structured care unit</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ECMO VV without dedicated unit</arm_group_label>
    <description>Patient having benefited from an ECMO without the structured care unit</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Collection of medical data</intervention_name>
    <description>Collection of adverse events, of mortality, length of hospitalization</description>
    <arm_group_label>ECMO VV dedicated unit</arm_group_label>
    <arm_group_label>ECMO VV without dedicated unit</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients supported by veno-venous ECMO&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient in an adult Dijon ICUs supported by veno-venous ECMO&#xD;
&#xD;
          -  patient hospitalized between January the 1st 2011 and June the 30th 2021&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Refusal to participate,&#xD;
&#xD;
          -  patient admitted to pediatric ICU&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Chu Dijon Bourogne</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 21, 2021</study_first_submitted>
  <study_first_submitted_qc>December 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2021</study_first_posted>
  <last_update_submitted>December 9, 2021</last_update_submitted>
  <last_update_submitted_qc>December 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

